Abstract-Met-Enkephalin injected i.c.v. attenuated stress-induced increases in levels of 3-methoxy-4-hydroxyphenylethyleneglycol sulfate, the major metabolite of brain noradrenaline, in the hypothalamus, amygdala, hippocampus, thalamus, midbrain and LC region in rats. The data suggest that Met-enkephalin acts to attenuate stress-induced increases in noradrenaline turnover in these brain regions in rats.
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By measuring the levels of noradrenaline (NA) and 3-methoxy-4-hydroxyphenyl ethyleneglycol sulfate (MHPG-S04) which is the major metabolite of rat brain NA and indicative of brain NA turnover (1 ), we have reported that naloxone enhances and morphine attenuates stress-induced increases in NA turnover in several brain regions in rats (2, 3) . From these results, it is hypo thesized that endogenous opioid peptides released during stress are partly involved in the stress process by attenuating stress induced increases in NA turnover in rat brain regions, especially in the hypothalamus and amygdala (3) . In order to confirm this hypo thesis, one such opioid peptide, methionine enkephalin (Met-enkephalin) injected intra cerebroventricularly (i.c.v.), was investigated with regard to its effects on stress-induced increases in MHPG-S04 level in six brain regions of rats.
Male Wistar rats (170-200 g) were anesthetized with pentobarbital and implanted with a polyethylene cannula into a lateral ventricle 4 days before the experiment began. Met-Enkephalin (Wako Pure Chemical Industries, Ltd.) at 100 /ig and 200 /€g (dissolved in 5 /cl of saline) per rat was used. These doses produce an analgesic action in rats (4) and in mice (5). Immediately after an i.c.v. injection with either saline (5 ucl) or an appropriate dose of Met-enkepahlin, the rats were stressed by immobilization within a wire mesh for 1 hr. Control animals were injected i.c.v. with saline 1 hr before sacrifice. Immediately after each treatment, the rats were sacrificed by decapitation.
The brain was dissected into discrete regions according to the method of Gispen et al. (6) and frozen on solid C02. The locus coeruleus (LC) region was dissected by the method of Reis and Ross (7). Blood was collected from the cervical wound into heparinized tubes. Dis sected tissues and separated plasma were stored at -45'C until assayed. M H PG-S04 levels in the brain regions and plasma corticosterone levels were determined fluorometrically by the method developed by us (8) and by the method of van der Vies (9), respectively. For statistical analysis, Student's t-test (two-tailed) was employed. One-hr immobilization stress caused sig nificant elevations of MHPG-S04 levels in all brain regions examined as compared with those in saline control rats (Table 1) , con sistent with the previous reports wherein it was reported that increases in the metabolite levels are accompanied by reductions of NA contents in most regions examined (2, 3, 10) . These findings again indicate that NA Both 100 i g and 200 /,tg of Met-enkephalin injected i.c.v. significantly attenuated the increases in MHPG-S04 levels induced by immobilization stress in all brain regions examined with the exception of the LC regions, wherein the increases were sig nificantly attenuated by Met-enkephalin at 100 iig and marginally (P<0.10) attenuated by Met-enkephalin at 200 aag. These findings suggest that Met-enkephalin acts to at tenuate stress-induced increases in NA turnover in the six brain regions examined. The fact that Met-enkepahlin applied ion tophoretically to the LC area produces inhibition of firing rates of some cells in this area (11) supports the present finding that Met-enkephalin attenuates stress-induced increases in NA turnover in the LC region as well as other brain areas. These attenuating effects of Met-enkephalin, however, did not occur in a dose-dependent manner, with the exception of the thalamus. The reason for this phenomnenon is uncertain; however, one possible explanation is that the dose range of Met-enkephalin used in the present study is not sufficient to differentiate the drug action on noradrenergic neurons, in particular, in the brain of stressed rats. This is likely, since both 3 mg/kg and 6 mg/kg of morphine injected subcutaneously also attenuate these increases in MHPG-S04 levels induced by stress; however, they fail to show a dose response relationship (3).
morphine. This result raises the possibility, supporting our view (2, 3) and that of Redmond and Huang (12) , that enhance ment of NA release by stress in these brain regions and its attenuation by Met enkephalin might be related to the regulation of "emotion" in animals exposed to stress. However, the present study is a preliminary one, and further studies on other opioid peptides, including the behavioral studies, would be needed to confirm this hypothesis.
